Rosh Pina, Israel-based IR-MED designed PressureSafe to support the early detection of pressure injuries (PI) to skin and underlying tissue.
In the study, PressureSafe demonstrated high efficacy in noninvasively detecting the presence and absence of pressure injuries below the skin. Sensitivity came in at 96% while specificity registered at 91%, IR-MED said in a news release.
Overall, the study performed 370 PressureSafe scans on 25 patients across two medical centers in Israel. These patients presented Stage 1 pressure injuries or deep tissue injuries. The study observed no device-related safety issues across a total of 44 patients evaluated for safety.
Dr. Yaniv Cohen, IR-MED chief science officer, said the company…